UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels

Biochemistry (Moscow), 2020-07, Vol.85 (7), p.758-772

2020

Volltextzugriff (PDF)

Epigenomics paves a new way to assess potential toxicity and chemotherapeutic response of breast tumours to 5-fluorouracil

Annals of oncology, 2018-09, Vol.29, p.vi12-vi12

2018

Volltextzugriff (PDF)

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

ESMO open, 2023-06, Vol.8 (3), p.101173-101173, Article 101173

2023

Volltextzugriff (PDF)

Remote Monitoring of the QT Interval During Polychemotherapy

Kardiologiia, 2023-05, Vol.63 (5), p.12-18

2023

Volltextzugriff (PDF)

Leukotriene B4 receptors as a therapeutic target for triple-negative breast cancer

Annals of oncology, 2018-09, Vol.29, p.vi26-vi26

2018

Volltextzugriff (PDF)

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity

Annals of oncology, 2018-10, Vol.29, p.viii56-viii56

2018

Volltextzugriff (PDF)

Place of imidazoline receptor agonists in the treatment of arterial hypertension

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2023-12, Vol.19 (6), p.603-606

2023

Volltextzugriff (PDF)

Influence of sex, age and length of service on scientific productivity of medical research institution staff

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2021-11, Vol.20 (7), p.2960

2021

Volltextzugriff (PDF)

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-10, Vol.373 (17), p.1627-1639

2015

Volltextzugriff (PDF)

Evidence-based pharmacotherapy in cardiology. National guideline

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2024-03, Vol.20 (1), p.105-170

2024

Volltextzugriff (PDF)

Assessment of structural and functional myocardial characteristics in patients with chronic coronary artery disease and various glycemic status

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2021-11, Vol.20 (7), p.3077

2021

Volltextzugriff (PDF)

Prehabilitation as an important stage before cardiac surgery

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2021-10, Vol.20 (6), p.2998

2021

Volltextzugriff (PDF)

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study

Sechenovskiĭ vestnik, 2019-12, Vol.10 (4), p.4-11

2019

Volltextzugriff (PDF)

Early echocardiographic alterations in cancer patients during chemotherapy

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2022-12, Vol.27 (11), p.5093

2022

Volltextzugriff (PDF)

DNA methylation in the promoter regions of the laminin family genes in normal and breast carcinoma tissues

Molecular biology (New York), 2015-07, Vol.49 (4), p.598-607

2015

Volltextzugriff (PDF)

Features of the management of cancer patients during the COVID-19 pandemic

Sechenovskiĭ vestnik, 2020-12, Vol.11 (2), p.62-73

2020

Volltextzugriff (PDF)

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1)

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2019-01, Vol.15 (5), p.725-735

2019

Volltextzugriff (PDF)

137P Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer

Annals of oncology, 2021-09, Vol.32, p.S419-S419

2021

Volltextzugriff (PDF)

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2018-09, Vol.20 (3), p.5-9

2018

Volltextzugriff (PDF)

1031P Tislelizumab (TIS) versus docetaxel (TAX) as second- or third-line therapy in previously treated patients (pts) with locally advanced non-small cell lung cancer (NSCLC): Asian versus non-Asian subgroup analysis of the RATIONALE-303 study

Annals of oncology, 2022-09, Vol.33, p.S1026-S1027

2022

Volltextzugriff (PDF)

509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

Annals of oncology, 2023-11, Vol.34, p.S1665-S1666

2023

Volltextzugriff (PDF)

LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

Annals of oncology, 2023-10, Vol.34, p.S1305-S1306

2023

Volltextzugriff (PDF)

THE REVIEW OF RUSSIAN PUBLICATIONS DURING THE YEARS 2010-2014. THE USE OF SCOPUS DATABASE FOR THE EVALUATION SPEED INTEGRATING INTO WORLDWIDE SCIENTIFIC SOCIETY

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2015-12, Vol.14 (6), p.66

2015

Volltextzugriff (PDF)

EP08.01-014 Tislelizumab versus Docetaxel in Previously Treated Advanced Non-Small Cell Lung Cancer: Final Analysis of RATIONALE-303

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S342-S343

2022

Volltextzugriff (PDF)

LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)

Annals of oncology, 2022-11, Vol.33, p.S1560-S1560

2022

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(82)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Humans
(11)
Cardiac & Cardiovascular Systems
(10)
Cardiovascular System & Cardiology
(10)
Chemotherapy
(6)
Female
(5)
Immunotherapy
(5)
Monoclonal Antibodies
(5)
Patients
(5)
Targeted Cancer Therapy
(5)
Adult
(4)
Aged
(4)
Antibodies, Monoclonal - Adverse Effects
(4)
Biomedical And Life Sciences
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Diabetes Mellitus
(4)
Lung Neoplasms - Drug Therapy
(4)
Male
(4)
Middle Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels

Epigenomics paves a new way to assess potential toxicity and chemotherapeutic response of breast tumours to 5-fluorouracil

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

Remote Monitoring of the QT Interval During Polychemotherapy

Leukotriene B4 receptors as a therapeutic target for triple-negative breast cancer

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity

Place of imidazoline receptor agonists in the treatment of arterial hypertension

Influence of sex, age and length of service on scientific productivity of medical research institution staff

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Evidence-based pharmacotherapy in cardiology. National guideline

Assessment of structural and functional myocardial characteristics in patients with chronic coronary artery disease and various glycemic status

Prehabilitation as an important stage before cardiac surgery

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study

Early echocardiographic alterations in cancer patients during chemotherapy

DNA methylation in the promoter regions of the laminin family genes in normal and breast carcinoma tissues

Features of the management of cancer patients during the COVID-19 pandemic

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1)

137P Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156

1031P Tislelizumab (TIS) versus docetaxel (TAX) as second- or third-line therapy in previously treated patients (pts) with locally advanced non-small cell lung cancer (NSCLC): Asian versus non-Asian subgroup analysis of the RATIONALE-303 study

509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

THE REVIEW OF RUSSIAN PUBLICATIONS DURING THE YEARS 2010-2014. THE USE OF SCOPUS DATABASE FOR THE EVALUATION SPEED INTEGRATING INTO WORLDWIDE SCIENTIFIC SOCIETY

EP08.01-014 Tislelizumab versus Docetaxel in Previously Treated Advanced Non-Small Cell Lung Cancer: Final Analysis of RATIONALE-303

LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)

Suchergebnisse filtern